GH1 and Creutzfeldt Jacob disease: Since 1985, 78 deaths from iatrogenic CJD have occurred in this cohort, and it has been identified that one particular preparation of UK pituitary-derived hGH (the Hartree-modified Wilhelmi preparation) had been administered to all hGH recipients who had developed iCJD [31, 33].